Estimating Overall Survival Treatment Effects in Oncology Trials: Hazard Ratio Instability and RMST as a Robust, Internally Predictive Complement
{{output}}
Objective: Overall survival (OS) is the definitive endpoint in oncology randomized controlled trials (RCTs), yet OS is often immature at interim analyses. Hazard ratio (HR) remains the dominant OS effect measure, but it depends o... ...
